ArticleAntimicrobial agents and chemotherapy2020

Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.

Grant Waterer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.